Physician profile
Joseph Herbert
NPI 1518319136
$4,398.60
in general payments reported to CMS, 2019-2025
22 companies · $778 in 2025
The $778 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $212 · 2021: $897 · 2022: $1,096 · 2023: $639 · 2024: $179 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091 · Travel and Lodging: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.64 |
| Travel and Lodging | $505.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $972.97 | 2019-2025 | Everest Spinal System, N/A |
| Medtronic, INC. | $818.22 | 2021-2025 | Midas Rex, Mazor X System |
| Globus Medical, INC. | $666.91 | 2023-2024 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Reline |
| Depuy Synthes Sales INC. | $283.06 | 2019-2025 | Viper, Teligen, Acis |
| Gs Solutions, INC. | $172.86 | 2022 | |
| Nevro Corp. | $163.12 | 2020 | |
| Cerapedics INC. | $156.42 | 2022 | |
| Si-Bone, INC. | $153.21 | 2022 | |
| Orthofix Medical, INC. | $145.95 | 2025 | Spinal-Stim, 7d Surgical System |
| Alphatec Spine, INC | $142.05 | 2025 | Other - Miscellaneous |
| Omniscient Neurotechnology America LTD | $138.00 | 2021 | |
| Arteriocyte Medical Systems, INC. | $128.47 | 2022 | |
| Integra Lifesciences Corporation | $118.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $99.71 | 2019 | |
| Medtronic USA, INC. | $76.51 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $48.82 | 2020 | |
| Biocomposites INC | $36.80 | 2022 | |
| Solventum Corporation | $32.46 | 2024 | V.A.C.Ulta |
| Ucb, INC. | $19.70 | 2023 | Briviact |
| Ulrich Medical USA, INC. | $13.21 | 2021 | |
| Covidien LP | $12.15 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Herbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.